Stevens Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-14,694
| Closed | -$891K | – | 231 |
|
|
2026
Q1 | $891K | Buy |
+14,694
| New | +$857K | 0.14% | 94 |
|
|
2025
Q3 | – | Sell |
-9,705
| Closed | -$449K | – | 263 |
|
|
2025
Q2 | $449K | Buy |
+9,705
| New | +$476K | 0.12% | 134 |
|
|
2025
Q1 | – | Sell |
-5,867
| Closed | -$332K | – | 253 |
|
|
2024
Q4 | $332K | Sell |
5,867
-22,625
| -79% | -$1.26M | 0.13% | 206 |
|
|
2024
Q3 | $1.47M | Buy |
+28,492
| New | +$1.34M | 0.21% | 60 |
|
|
2023
Q4 | – | Sell |
-16,098
| Closed | -$934K | – | 254 |
|
|
2023
Q3 | $934K | Sell |
16,098
-10,492
| -39% | -$643K | 0.27% | 92 |
|
|
2023
Q2 | $1.7M | Buy |
26,590
+22,025
| +482% | +$1.48M | 0.35% | 60 |
|
|
2023
Q1 | $316K | Buy |
+4,565
| New | +$322K | 0.08% | 150 |
|
|
2021
Q4 | – | Sell |
-39,862
| Closed | -$2.36M | – | 240 |
|
|
2021
Q3 | $2.36M | Buy |
+39,862
| New | +$2.63M | 0.99% | 26 |
|
|
2021
Q2 | – | Sell |
-18,694
| Closed | -$1.18M | – | 196 |
|
|
2021
Q1 | $1.18M | Buy |
+18,694
| New | +$1.16M | 0.65% | 30 |
|
|
2020
Q1 | – | Sell |
-105,145
| Closed | -$6.75M | – | 50 |
|
|
2019
Q4 | $6.75M | Buy |
105,145
+21,410
| +26% | +$1.23M | 0.63% | 38 |
|
|
2019
Q3 | $4.25M | Sell |
83,735
-104,070
| -55% | -$4.89M | 0.38% | 74 |
|
|
2019
Q2 | $8.52M | Sell |
187,805
-39,149
| -17% | -$1.82M | 0.38% | 68 |
|
|
2019
Q1 | $10.8M | Buy |
+226,954
| New | +$11.3M | 0.46% | 55 |
|
|
2016
Q4 | – | Sell |
-97,875
| Closed | -$5.28M | – | 881 |
|
|
2016
Q3 | $5.28M | Buy |
+97,875
| New | +$6.29M | 0.22% | 123 |
|
|
2016
Q2 | – | Sell |
-18,831
| Closed | -$1.2M | – | 911 |
|
|
2016
Q1 | $1.2M | Buy |
+18,831
| New | +$1.19M | 0.05% | 377 |
|
|
2015
Q2 | – | Sell |
-12,914
| Closed | -$833K | – | 1029 |
|
|
2015
Q1 | $833K | Buy |
+12,914
| New | +$808K | 0.03% | 455 |
|
|
2014
Q3 | – | Sell |
-4,506
| Closed | -$219K | – | 1007 |
|
|
2014
Q2 | $219K | Sell |
4,506
-79,275
| -95% | -$3.91M | 0.01% | 905 |
|
|
2014
Q1 | $4.35M | Buy |
+83,781
| New | +$4.46M | 0.12% | 210 |
|
|
2013
Q3 | – | Sell |
-9,588
| Closed | -$428K | – | 1030 |
|
|
2013
Q2 | $428K | Buy |
+9,588
| New | +$416K | 0.01% | 616 |
|
Other funds holding BMY
Stevens Capital Management's BMY Position: Q2 2026 in Review
Stevens Capital Management sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 14,694 shares — an estimated $891K sold.
Stevens Capital Management first reported a position in BMY in Q2 2013 and held it in 19 quarters. The position peaked at $10.8M in Q1 2019. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Stevens Capital Management reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
- Stevens Capital Management sold 14,694 Bristol-Myers Squibb shares in Q2 2026, an estimated $891K.
- Stevens Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 19 quarters.
- Stevens Capital Management's Bristol-Myers Squibb position peaked at $10.8M in Q1 2019.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Stevens Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.